Danaher Gestione
Gestione criteri di controllo 3/4
Danaher Il CEO è Rainer Blair, nominato in Sep2020, e ha un mandato di 4.17 anni. la retribuzione annua totale è $ 20.90M, composta da 6.2% di stipendio e 93.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.014% delle azioni della società, per un valore di $ 22.85M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.8 anni e 14.5 anni.
Informazioni chiave
Rainer Blair
Amministratore delegato
US$20.9m
Compenso totale
| Percentuale dello stipendio del CEO | 6.2% |
| Mandato del CEO | 4.2yrs |
| Proprietà del CEO | 0.01% |
| Durata media del management | 5.8yrs |
| Durata media del Consiglio di amministrazione | 14.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Understanding Danaher's Cautiousness
Oct 25Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28
Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year
May 01Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price
Sep 30Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 28Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?
Jun 15Danaher: A Great Chance To Buy This Long-Term Compounder
May 23With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case
Apr 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 27 2024 | n/a | n/a | US$4b |
| Jun 28 2024 | n/a | n/a | US$4b |
| Mar 29 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$21m | US$1m | US$4b |
| Sep 29 2023 | n/a | n/a | US$4b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$20m | US$1m | US$6b |
| Sep 30 2022 | n/a | n/a | US$7b |
| Jul 01 2022 | n/a | n/a | US$6b |
| Apr 01 2022 | n/a | n/a | US$6b |
| Dec 31 2021 | US$17m | US$1m | US$5b |
| Oct 01 2021 | n/a | n/a | US$6b |
| Jul 02 2021 | n/a | n/a | US$5b |
| Apr 02 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$10m | US$949k | US$4b |
| Oct 02 2020 | n/a | n/a | US$3b |
| Jul 03 2020 | n/a | n/a | US$3b |
| Apr 03 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$7m | US$840k | US$2b |
| Sep 27 2019 | n/a | n/a | US$2b |
| Jun 28 2019 | n/a | n/a | US$2b |
| Mar 29 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$5m | US$700k | US$2b |
| Sep 28 2018 | n/a | n/a | US$3b |
| Jun 29 2018 | n/a | n/a | US$3b |
| Mar 30 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$4m | US$625k | US$2b |
Compensazione vs Mercato: La retribuzione totale di Rainer ($USD 20.90M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 12.73M ).
Compensazione vs guadagni: La retribuzione di Rainer è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Rainer Blair (60 yo)
4.2yrs
Mandato
US$20,903,282
Compensazione
Mr. Rainer M. Blair serves as an Independent Non-Executive Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Chairman | 41.8yrs | Nessun dato | 6.02% $ 10.1b | |
| President | 4.2yrs | US$20.90m | 0.014% $ 22.8m | |
| Co-Founder & Director | 41.8yrs | Nessun dato | 4.86% $ 8.2b | |
| CFO & Executive VP | 5.8yrs | US$7.50m | 0.0053% $ 8.9m | |
| Senior VP & Chief Science Officer | 3.9yrs | US$7.20m | 0.00037% $ 622.9k | |
| Senior Vice President of Human Resources | 2.6yrs | US$5.25m | 0.00015% $ 252.5k | |
| VP & Chief Accounting Officer | 2.8yrs | Nessun dato | 0.00081% $ 1.4m | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Senior VP | 8.8yrs | US$3.56m | 0.0028% $ 4.7m | |
| Senior Vice President of Corporate Development | 14.8yrs | Nessun dato | 0.0033% $ 5.5m | |
| Senior Vice President of Strategic Development | 10.5yrs | Nessun dato | 0.0067% $ 11.2m | |
| Executive VP of Biotechnology Group & CEO of Cytiva | less than a year | Nessun dato | 0.0020% $ 3.4m |
5.8yrs
Durata media
57yo
Età media
Gestione esperta: Il team dirigenziale di DHR è esperto e expertise (durata media dell'incarico 5.8 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Chairman | 41.8yrs | Nessun dato | 6.02% $ 10.1b | |
| President | 4.2yrs | US$20.90m | 0.014% $ 22.8m | |
| Co-Founder & Director | 41.8yrs | Nessun dato | 4.86% $ 8.2b | |
| Independent Director | 25.8yrs | US$338.13k | 0.011% $ 19.0m | |
| Independent Director | 21.3yrs | US$351.13k | 0.0054% $ 9.1m | |
| Independent Director | 15.8yrs | US$338.13k | 0.0024% $ 4.0m | |
| Independent Director | 7.8yrs | US$318.13k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.6yrs | Nessun dato | Nessun dato | |
| Lead Independent Director | 18.9yrs | US$382.13k | 0.0057% $ 9.6m | |
| Independent Director | 13.2yrs | US$318.13k | 0% $ 0 | |
| Independent Director | 5yrs | US$318.13k | 0% $ 0 | |
| Director | 5yrs | US$318.13k | 0% $ 0 |
14.5yrs
Durata media
64yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di DHR è composto da personale esperto e esperto (durata media dell'incarico 14.5 anni).